Displaying 1-10 of 10 result(s).
| Board Name | Posts By Decemberschild | Post Created |
|---|---|---|
| FITX Creative Edge Nutrition Inc. | that is indeed what I meant...there  (1) | 04/06/2016 11:39:57 PM |
| FITX Creative Edge Nutrition Inc. | more with ownership issues than wro | 04/05/2016 11:28:25 PM |
| FITX Creative Edge Nutrition Inc. | Not quite sure why you think the SE | 04/05/2016 10:45:45 PM |
| FITX Creative Edge Nutrition Inc. | Obviously a change is not as good a | 04/03/2016 11:37:00 PM |
| FITX Creative Edge Nutrition Inc. | I thought personal attacks were for (2) | 04/03/2016 7:07:20 PM |
| FITX Creative Edge Nutrition Inc. | You posted the email, that was enou (2) | 04/02/2016 12:21:00 AM |
| FITX Creative Edge Nutrition Inc. | You can but it is very annoying bec | 04/02/2016 12:09:49 AM |
| FITX Creative Edge Nutrition Inc. | I lurked around this board for over | 04/01/2016 12:32:13 PM |
| FITX Creative Edge Nutrition Inc. | I just want to ensure this board do (2) | 04/01/2016 10:26:07 AM |
| FITX Creative Edge Nutrition Inc. | That is fair as long as that applie (1) | 04/01/2016 9:50:57 AM |
Recent Articles
- StreetLeaf Reaches Milestone: 10,000 Solar Lights Installed
- NIO Inc. Announces Increased Vehicle Deliveries for May 2025
- InxMed Reports Strong Efficacy Data from Clinical Trials
- XPENG Reports Record-High Electric Vehicle Deliveries
- Li Auto's May 2025 Deliveries Show Robust Growth in EV Market
- Innovent Biologics Unveils Promising IBI363 Melanoma Data
- Zeekr Group Achieves Strong Vehicle Deliveries in 2025
- Innovative Collaboration to Enhance Eyecare Treatments Nationwide
- Exciting Advances in LBL-024 for Advanced Neuroendocrine Cancer
- oneworld Alliance Expands Leadership for Global Growth Strategies
- Linkin Park Shines at UEFA Champions League Kickoff Show 2025
- Flex's Leadership to Present at Major Investor Conference
- Revolutionary Findings on Elraglusib for Pancreatic Cancer
- Boosting Domestic Aluminum: APAA's Take on New Tariff Laws
- Navigating Long-Term Care Insurance Disputes with Fenton & Keller
- PFM CRYPTO Unveils Innovative 2-Day XRP Mining Solution
- Zenas BioPharma Securities Lawsuit: Understanding Your Rights
- Investors' Chance to Lead NET Power Class Action Lawsuit
- Investigation Paves Way for Bakkt Holdings' Shareholder Actions
- Last Chance to Buy $XDX: Join XenDex's Exciting Presale
- Strengthening Global Integrity Efforts for Anti-Corruption
- XenDex $XDX Token: Presale Countdown and Upcoming Launch Plans
- Nimanode's $NMA Presale: Pioneering AI in Web3 Automation
- Investors Unite: Action Options for Bakkt Holdings, Inc. Claims
- Transforming Lives: A Raffle to Combat Housing Insecurity
- Krispy Kreme Investors Initiate Class Action Over Losses
- Potential Economic Fallout from Mongolia's Political Crisis
- Explore BexBack's Incredible Bonuses and Leverage Trading
- Explore the Affordable Car Insurance Options in Georgia
- Exploring Future Opportunities at the Nanjing Business Conference
- Western China International Fair: Expanding Global Opportunities
- Cerevel Therapeutics Faces Class Action Claims Amid Investigation
- Innovative Steps in Tobacco Harm Reduction: The TNFS Initiative
- Examining Week 19 of Leadership Highlights Under Trump
- Investors Alert: Zenas BioPharma Under Investigation by Law Firm
- Investors of BigBear.ai: Important Legal Insights Ahead
- Faruqi & Faruqi Investigates Viatris Investor Claims
- Investigation Announced for Avis Budget Group Investors
- Dignity Made: Pioneering Ethical Coconut Oil to Empower Communities
- Golden Goblet Awards Set to Dazzle with Impressive Films
- Investors' Alert: Potential Legal Action Against NET Power Explored
- Important Update for Investors in Open Lending Securities
- Investors Alert: Ibotta Facing Lawsuit Over Misleading Claims
- Inspiring Young Minds: Success in Youth Entrepreneurship Challenge
- Innovative Cell Therapy Yields Promising Results in Melanoma Treatment
- Latest Insights on Onivyde's Role in Pancreatic Cancer Survival
- Xilio Therapeutics Expands Hope for Colorectal Cancer Patients
- Arvinas and Pfizer Unveil Game-Changing Cancer Treatment Results
- Regeneron Unveils Libtayo's Impact on Skin Cancer Treatment
- Roche's Itovebi Shows Promise in Extending Breast Cancer Survival